Radiation oncology

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS86
Academic Journal
Presents an abstract of the research manuscript `Primary mucosal melanoma of nasal cavity, BCCA experience,' by R. Ma et al. British Columbia Cancer Agency (BCCA).


Related Articles

  • New device can detect skin cancer in seconds.  // South Asian Post;5/24/2012, p8 

    The article provides information on Verisante Aura, a device used for the diagnosis of melanoma, developed by the British Columbia Cancer Agency.

  • Primary sinonasal malignant melanoma: A clinicopathologic and prognostic study. Kumar, Sudesh; Gupta, Ashok K.; Yadav, Budhi S.; Ghoshal, Sushmita // ENT: Ear, Nose & Throat Journal;Dec2009, Vol. 88 Issue 12, p1269 

    We conducted a retrospective study to evaluate the clinicopathologic features and prognostic factors associated with primary sinonasal malignant melanoma. We reviewed the records of 10 patients--7 men and 3 women, aged 35 to 70 years (mean: 51.4)--who had been treated at our referral center over...

  • Leiomyoma of the Inferior Turbinates. Huang, Cheng-Tsung; Chien, Chih-Yen; Su, Chih-Ying; Chen, Wei-Jen // Journal of Otolaryngology;Jan/Feb2000, Vol. 29 Issue 1, p55 

    Reports on the case of a 20-year old man diagnosed with leiomyoma of the inferior turbinate of the nasal cavity. Medical history; Initial assessment; Pathologic findings; Occurrence of leiomyomas wherever the smooth muscle is present; Identification of three subtypes of leiomyoma;...

  • Nasal glioma presenting as capillary haemangioma. Hoeger, Peter H.; Schaefer, Hansjörg; Ussmueller, Jürgen; Helmke, Knut // European Journal of Pediatrics;2001, Vol. 160 Issue 2, p84 

    Abstract We report the case of a 5-month-old female infant with a congenital nasal tumour originally attributed to a capillary haemangioma. Doppler-flow ultrasound imaging revealed a solid mass surrounded by mildly enlarged vessels which had a flow pattern atypical of haemangioma. Histology...

  • British Columbia Cancer Agency Joins the Illumina Genome Network.  // Biomedical Market Newsletter;12/21/2011, Vol. 21, p1 

    The article presents information on an announcement made by Illumina Inc. on the joining of Genome Science Center of British Columbia Cancer Agency (BCCA) to the Illumina Genome Network (IGN). IGN is designed to link the researchers who need whole human genome sequencing with major institutions...

  • The human genome leads back to BC. Kent, Heather // CMAJ: Canadian Medical Association Journal;1/23/2001, Vol. 164 Issue 2, p312 

    Profiles research scientist Marco Marra who works at the Genome Sequence Center at the British Columbia Cancer Agency. His works on projects involving the International Human Genome Project; His interest in endocrinology; How knowing a person's DNA sequence may influence the choice of drugs for...

  • Extensive nasopharyngeal angiofibromas: the maxillary swing approach. Mathur, Neeraj; Vashishth, Ashish // European Archives of Oto-Rhino-Laryngology;Nov2014, Vol. 271 Issue 11, p3035 

    The objective of this study was to evaluate the efficacy and outcome using the maxillary swing approach for the management of extensive nasopharyngeal angiofibromas. A retrospective analysis in a tertiary care center revealed five cases with extensive nasal angiofibromas operated using the...

  • Antrochoanal polyp displacing the uvula and the soft palate. Christmas, Dewey A.; Yanagisawa, Ken; Yanagisawa, Eiji // ENT: Ear, Nose & Throat Journal;May2003, Vol. 82 Issue 5, p347 

    Presents an examination of antrochoanal polyp displacing the uvula and the soft palate of a patient. Symptoms of the disorder; Diagnosis of antrochoanal polyp; Information on an endoscopic excision of the polyp performed on the patient.

  • Extramedullary plasmacytoma of the nasal cavity: Treatment perspective in a developing nation. Grover, Nancy; Chary, Geetha; Makhija, Purnima; Rout, Pritilata // ENT: Ear, Nose & Throat Journal;Jul2006, Vol. 85 Issue 7, p434 

    Extramedullary plasmacytomas are uncommon tumors, with a worldwide annual incidence of 3 per 100,000 population. They account for 1% of all tumors of the head and neck and 4% of all nonepithelial tumors of the nasal tract. A variety of treatment options has been suggested. These treatments vary...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics